{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T23:04:58Z","timestamp":1766012698317,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00520-021-06681-0","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T20:04:19Z","timestamp":1637697859000},"page":"2621-2629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prospective external validation of an updated algorithm to quantify risk of febrile neutropenia in cancer patients after a cycle of chemotherapy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-8103","authenticated-orcid":false,"given":"Hakan","family":"Bozcuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan \u015eenol","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"\u0130lhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema Sezgin","family":"G\u00f6ksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selami","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Ko\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Arta\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"U\u011frakl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayberk","family":"Ouisupov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Aydeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilhun","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6zde","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meliha","family":"Saat\u00e7i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"6681_CR1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00520-014-2531-6","volume":"23","author":"H Bozcuk","year":"2015","unstructured":"Bozcuk H, Ulukal E, Ay S et al (2015) A prospectively validated nomogram for predicting the risk of chemotherapy-induced febrile neutropenia: a multicenter study. Support Care Cancer 23:1759\u20131767","journal-title":"Support Care Cancer"},{"key":"6681_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00520-010-0816-y","volume":"18","author":"M Aapro","year":"2010","unstructured":"Aapro M, Crawford J, Didier K (2010) Prophylaxis of chemotherapy induced febrile neutropenia with granulocyte colony stimulating factors: where are we know? Support Care Cancer 18:549\u2013541","journal-title":"Support Care Cancer"},{"key":"6681_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1634\/theoncologist.10-6-427","volume":"10","author":"GH Lynman","year":"2005","unstructured":"Lynman GH, Lynman CH, Agboola O (2005) Risk models for chemotherapy-induced neutropenia. Oncologist 10:427\u2013437","journal-title":"Oncologist"},{"key":"6681_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1365-2141.2008.07514.x","volume":"144","author":"R Pettengell","year":"2009","unstructured":"Pettengell R, Bosly A, Szucs TD et al (2009) Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU prospective observational European Neutropenia Study. Br J Haematol 144:677\u2013685","journal-title":"Br J Haematol"},{"key":"6681_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/annonc\/mdm541","volume":"19","author":"M Ziepert","year":"2008","unstructured":"Ziepert M, Schmits R, Trumper L et al (2008) Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol 19:752\u2013762","journal-title":"Ann Oncol"},{"issue":"4","key":"6681_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","volume":"17","author":"B Yi","year":"2020","unstructured":"Yi B, Yuankai S, Wenqi J et al (2020) Current management of chemotherapy-induced neutropenia in adults: key points and new challenges. Cancer Biol Med 17(4):896\u2013909","journal-title":"Cancer Biol Med"},{"issue":"3","key":"6681_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/03007995.2019.1703665","volume":"36","author":"J Edelsberg","year":"2020","unstructured":"Edelsberg J, Weycker D, Bensink M, Bowers C, Lyman GH (2020) Prophylaxis of febrile neutropenia with colony-stimulating factors: the first 25 years. Curr Med Res Opin 36(3):483\u2013495","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"6681_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.6004\/jnccn.2017.7038","volume":"15","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Poniewierski MS (2017) A patient risk model of chemotherapy-induced febrile neutropenia: lessons learned from the ANC Study Group. J Natl Compr Canc Netw 15(12):1543\u20131550","journal-title":"J Natl Compr Canc Netw"},{"key":"6681_CR9","unstructured":"Febrile neutropenia wise app. At \u201chttps:\/\/previewer.adalo.com\/cbb83bdf-d9ac-4bd6-a434-fad5c3ab5362?target=998942e43ce445e7a8ed43cc51862f42&params=%7B%7D\u201d. Accessed February 2021"},{"key":"6681_CR10","unstructured":"Receiver Operating Characteristic. At \u201chttps:\/\/en.wikipedia.org\/wiki\/Receiver_operating_characteristic\u201d. Accessed February 2021"},{"key":"6681_CR11","unstructured":"Febrile Neutropenia Wise App. At \u201chttps:\/\/www.febrileneutropeniawise.com\u201d.\u00a0Accessed February 2021"},{"key":"6681_CR12","unstructured":"Adalo. At \u201chttps:\/\/www.adalo.com\u201d.\u00a0Accessed\u00a0 February 2021"},{"key":"6681_CR13","unstructured":"IBM Support. At \u201chttps:\/\/www.ibm.com\/support\/pages\/spss-statistics-210-available-download\u201d.\u00a0Accessed February 2021"},{"key":"6681_CR14","unstructured":"NCSS 9 Update. At \u201chttps:\/\/www.ncss.com\/download\/ncss\/updates\/ncss-9\u201d.\u00a0Accessed February 2021"},{"key":"6681_CR15","unstructured":"Florkowski CM (2008). Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests 29(1): 83\u201387."},{"key":"6681_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/COC.0b013e318165c01d","volume":"31","author":"G Dranisatris","year":"2008","unstructured":"Dranisatris G, Rayson D, Vincent M et al (2008) Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model. Am J Clin Oncol 31:369\u2013374","journal-title":"Am J Clin Oncol"},{"key":"6681_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12957-019-1665-x","volume":"17","author":"Y Okhura","year":"2019","unstructured":"Okhura Y, Ueno M, Udagawa H et al (2019) Risk factors for febrile neutropenia and effectiveness of primary prophylaxis with pegfilgrastim in patients with esophageal cancer treated with docetaxel, cisplatin, and 5-fluorouracil. World J Surg Onc 17:125","journal-title":"World J Surg Onc"},{"key":"6681_CR18","doi-asserted-by":"publisher","first-page":"6964529","DOI":"10.1155\/2018\/6964529","volume":"2018","author":"M Lappalainen","year":"2018","unstructured":"Lappalainen M, Jokkala J, Juutilainen A et al (2018) Novel biomarker candidates for febrile neutropenia in hematological patients using nontargeted metabolomics. Dis Markers 2018:6964529","journal-title":"Dis Markers"},{"key":"6681_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/1471-2407-14-201","volume":"14","author":"AM Pfeil","year":"2014","unstructured":"Pfeil AM, Vulsteke C, Paridaens R et al (2014) Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors. BMC Cancer 14:201","journal-title":"BMC Cancer"},{"issue":"3","key":"6681_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bcp.13477","volume":"84","author":"I Netterberg","year":"2018","unstructured":"Netterberg I, Karllson MO, Nielsen EI et al (2018) The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling. Br J Clin Pharmacol 84(3):490\u2013500","journal-title":"Br J Clin Pharmacol"},{"key":"6681_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41512-016-0002-x","volume":"1","author":"B Van Calster","year":"2017","unstructured":"Van Calster B, Van Hoorde K, Vergouwe Y et al (2017) Validation and updating of risk models based on multinomial logistic regression. Diagnostic and Prognostic Research 1:2","journal-title":"Diagnostic and Prognostic Research"},{"key":"6681_CR22","doi-asserted-by":"publisher","first-page":"b605","DOI":"10.1136\/bmj.b605","volume":"338","author":"DG Altman","year":"2009","unstructured":"Altman DG, Vergouwe Y, Royston P et al (2009) Prognosis and prognostic research. BMJ 338:b605","journal-title":"BMJ"},{"issue":"5","key":"6681_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/AJP.0000000000000413","volume":"33","author":"S Bj\u00f6rn","year":"2017","unstructured":"Bj\u00f6rn S, Audrey AA, Marco MA et al (2017) External validation and modification of a predictive model for acute postsurgical pain at home after day surgery. Clin J Pain 33(5):405\u2013413","journal-title":"Clin J Pain"},{"key":"6681_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/1471-2407-11-404","volume":"11","author":"KL Cooper","year":"2011","unstructured":"Cooper KL, Madan J, Whyte S et al (2011) Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC Cancer 11:404","journal-title":"BMC Cancer"},{"issue":"9","key":"6681_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.4065\/80.9.1122","volume":"80","author":"M Paul","year":"2005","unstructured":"Paul M (2005) Systematic reviews and meta-analysis of febrile neutropenia. Mayo Clin Proc 80(9):1122\u20131125","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"6681_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.critrevonc.2014.12.011","volume":"94","author":"XJ Wang","year":"2015","unstructured":"Wang XJ, Lopez SE, Chan A (2015) Economic burden of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review. Crit Rev Oncol Hematol 94(2):201\u2013212","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06681-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T08:14:13Z","timestamp":1643271253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["6681"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06681-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"assertion":[{"value":"7 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the medical ethics committee of Akdeniz University, Antalya.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This is an observational study of patient records and outcome. No intervention has been made, and no consent to participate was collected from the subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The manuscript has been read and approved by all the authors, the requirements for authorship as stated above in this document have been met, and each author believes that the manuscript represents honest work, and consents to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Prof. Dr. Hakan Bozcuk has produced a freely available web application that makes use of this algorithm, and collects data on parameters of febrile neutropenia. The other authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}